FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Lilly Hopeful Obesity Pill Accepted in Voucher Program

[ Price : $8.95]

Eli Lilly says its investigational weight-loss pill met most criteria for FDAs new national priority voucher program and could be ...

J&J Seeks Stelara Expanded Use

[ Price : $8.95]

Johnson & Johnson files a supplemental BLA seeking to expand the use of its biologic therapy Stelara (ustekinumab) to treat childr...

Improving Cancer Trial Comparators: White Paper

[ Price : $8.95]

A Friends of Cancer Research working group suggests ways to overcome challenges in selecting standard of care comparators for onco...

Zydus Lifesciences FDA-483 Out

[ Price : $8.95]

FDA releases the form FDA-483 with four observations from an inspection at the Zydus drug manufacturing facility in Baddi, India.

Clinical Hold on 2 Intellia Gene Therapy Trials

[ Price : $8.95]

FDA issues a clinical hold on Intellia Therapeutics MAGNITUDE and MAGNITUDE-2 Phase 3 trials for nexiguran ziclumeran after the co...

FDA Clears Tosohs Next-Generation HbA1c Analyzer

[ Price : $8.95]

FDA clears a Tosoh Bioscience 510(k) for its next-generation Automated Glycohemoglobin Analyzer for rapid HbA1c (blood sugar) test...

Lantheus NDA for Imaging Agent Accepted

[ Price : $8.95]

FDA accepts for review a Lantheus NDA for LNTH-2501 (Gallium-68 edotreotide), a diagnostic kit for the preparation of Ga 68 edotre...

Senators Want Foreign Generic Drug Info

[ Price : $8.95]

Leaders of the Senate Special Committee on Aging ask executives of three group purchasing organizations a series of questions abou...

Hire Staff, Improve Morale, Cut INDs: Tidmarsh Goals

[ Price : $8.95]

New CDER director George Tidmarsh talks about hiring new reviewers, improving staff morale, and finding ways to safely speed drug ...

FDA Fast Track for Alphamab Cancer Drug

[ Price : $8.95]

FDA grants fast-track designation to Alphamab Oncologys JSKN003 to treat several cancers.